Is the intrauterine device appropriate contraception for HIV-1-infected women?

British Journal of Obstetrics and Gynaecology

Volumn 108, Issue 8, 2001, Pages 784-790

  Morrison, Charles S ^a   Sekadde Kigondu, Christine ^b   Sinei, Samuel K ^b   Weiner, Debra H ^a   Kwok, Cynthia ^a   Kokonya, Donald ^b  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DEVICE REMOVAL; FEMALE; FOLLOW UP; GYNECOLOGIC INFECTION; HEALTH HAZARD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; INTRAUTERINE CONTRACEPTIVE DEVICE; KENYA; MAJOR CLINICAL STUDY; MEDICAL SERVICE; PAIN; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SAFETY; UTERUS BLEEDING;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTRAUTERINE DEVICES; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 0034928887     PISSN: 03065456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-5456(00)00204-7     Document Type: Article

References (28)

1. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors
2. IUCD use throughout the world: Past, present, and future
3. Intrauterine devices and pelvic inflammatory disease: An international perspective
4. IMAP statement on HIV infection and AIDS
5. Complications of use of intrauterine devices among HIV-1-infected women
6. Criteria for diagnosis and grading of salpingitis
7. The impact of confounder selection criteria on effect estimation
8. What risk of infection with IUCD use?
9. Preventing IUCD-related pelvic infection: The efficacy of prophylactic doxycycline at insertion
10. Prevention of IUCD-related pelvic infection: The efficacy of prophylactic doxycycline at IUCD insertion
11. Use of sexually transmitted disease risk assessment algorithms for selection of intrauterine device candidates
12. Successful use of levonorgestrel intrauterine system in a HIV positive woman
13. Effect of intrauterine device use on cervical shedding of HIV-1 DNA
14. Comparison of female to male and male to female transmission of HIV-1 in 563 stable couples
15. Detection of HIV-1 DNA in cervical and vaginal secretions: Prevalence and correlates among women in Nairobi, Kenya
16. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina
17. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA
18. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire
19. IUCD use and man to woman sexual transmission of HIV-1
20. Man-to-woman sexual transmission of the human immunodeficiency virus: Risk factors related to sexual behaviour, man's infectiousness, and woman's susceptibility
21. Contraceptive use and the risk of HIV-1 infection in Nairobi, Kenya
22. Risk factors for male to female transmission of HIV-1
23. Human immunodeficiency virus transmission among heterosexual couples in Central Africa
24. Human immunodeficiency virus type 1 infection in women attending a sexually transmitted diseases clinic in Kenya
25. The incidence of HIV-1 infection among women using family planning methods in Dares-Salaam, Tanzania
26. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of Human Immunodeficiency Virus Type 1